Premium Membership - Holiday Season Special - 75% off

investorscraft@gmail.com

Investor's Craft

Stock Screeners
Stock Indices
Stock Valuation

Intrinsic Value of Nektar Therapeutics (NKTR)

Previous Close$1.07
Intrinsic Value$1.67
Upside potential  +56%
Previous Close
$1.07
Intrinsic Value
$1.67
Potential        
+56%

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

Intrinsic Value Stock Screener
Artificial intelligence value of

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-9.7NaN
Revenue, $92NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m468NaN
Operating income, $m-376NaN
EBITDA, $m-363NaN
Interest expense (income), $mNaN
Earnings before tax, $m-365NaN
Tax expense, $m3NaN
Net income, $m-368NaN

BALANCE SHEET

Cash and short-term investments, $m505NaN
Total assets, $m711NaN
Adjusted assets (=assets-cash), $m206NaN
Average production assets, $m123NaN
Working capital, $m478NaN
Total debt, $m258NaN
Total liabilities, $m344NaN
Total equity, $m367NaN
Debt-to-equity ratio0.704NaN
Adjusted equity ratio-0.580NaN

CASH FLOW

Net income, $m-368NaN
Depreciation, amort., depletion, $m13NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-304NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m8NaN
Free cash flow, $m-312NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m478
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount